首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2105105

全球臨床實驗室服務市場（第11版）

Worldwide Market for Clinical Laboratory Services, 11th Edition

出版日期: 2026年07月31日 | 出版商:

Kalorama Information | 英文 279 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

這份權威的全球臨床實驗室服務產業調查涵蓋市場規模、細分市場分析以及 2030 年的預測。

Kalorama Information 的旗艦報告《臨床實驗室服務報告》現已發佈至第 11 版，為決策者提供對當前診斷檢測收入水平及其未來發展趨勢的嚴謹獨立的分析。該報告以 2025 年為基準年，涵蓋 2020 年至 2024 年的歷史數據，並預測至 2030 年，是相關人員了解市場規模、與競爭對手進行比較以及根據人口統計、臨床、技術和報銷等實際情況檢驗戰略的基準。

為什麼這份報告現在如此重要？

臨床檢查室是診斷流程的核心，作為體外診斷試劑最大的終端使用者之一，它們為生物化學、血液學、免疫學、微生物學、病理學、遺傳學和分子診斷等領域的決策提供支援。進行這些檢測的醫療環境正在快速變化。儘管樣本採集方式正逐漸轉向門診、診所、零售和居家採集等外部檢體方式，但高度複雜的分子和基因組診斷也趨於集中化，集中在參考實驗室、學術機構和專業機構。此外，人口老化、慢性病負擔加重、腫瘤學領域對分子診斷和伴隨診斷的日益依賴、持續的價格和報銷壓力、人才短缺以及行業加速重組等多種因素正在重塑競爭格局。在本期中，我們將基於數據而非推測來揭示這一競爭格局。

本報告內容

報告提供了市場規模和預測數據，包括全球服務供應商層面的年度收入數據、2025年至2030年的預測數據以及各主要細分市場的複合年成長率。

專業檢測服務。我們針對六個細分市場分別提供市場規模、趨勢線和成長預測：基礎和常規檢測（臨床化學、血液學、血液凝固檢驗、內分泌學）、免疫學和微生物學、細胞學和組織學、基因檢測、毒理學（濫用藥物）以及新冠病毒檢測。這包括隨著疫情常態化，常規檢測和專業檢測之間的檢測量重新分配情況。

按供應商群體分類的市場細分。此細分包括醫院和急診檢查室、醫生和門診供應商以及獨立實驗室和參考檢查室，並考慮了醫院床位數量和醫生密度等基準，以及長期照護、居家醫療、透析和藥房檢查室等環境因素。

我們對四大區域、15個國家進行了詳細的區域分析：北美（美國、加拿大）、歐洲、中東和非洲地區（德國、法國、義大利、西班牙、英國、瑞士）、亞太地區（日本、中國、印度、韓國、澳洲）以及拉丁美洲（巴西、墨西哥）。針對每個區域，我們提供了關鍵市場中各國具體的市場規模、表現、成長預測和產業結構等詳細資訊。

法規和報銷資訊。影響利潤率的因素的實用說明——CLIA結構和認證趨勢、檢查室自建檢測（LDT）法規、歐盟體外診斷醫療器械法規（IVDR）、聯邦醫療保險報銷趨勢、PAMA和CARES法案、SALSA、ADLT指定、末期腎臟病（ESRD）合併索賠、私人保險公司趨勢、價格透明度等。

競爭分析和公司概況。除了分析主要公司的市場佔有率外，我們還提供塑造全球競爭格局的公司概況，包括 ARUP、BioReference Health、DaVita、Eurofins Scientific、Exact Sciences、Guardant Health、HU Group、Labcorp、Medicover、Myriad Genetics、Natera、Quest Diagnostics、Siemens HealthNL、Sonic、Myriad Genetics、Natera、Quest Diagnostics、Siemens HealthNL Unilabs，說明它們的公司概況、收入趨勢、收購、合作夥伴關係和夥伴關係活動。

2025-2030 年的發展趨勢：我們提供關於人工智慧、機器學習、檢查室自動化、分子和先進檢測、數位病理學、多參數檢測、個人化醫療、產業重組和集中式網路、定價和報銷壓力以及人才短缺等方面的專業分析。

可靠的調查方法

研究結果是基於對行業相關人員、顧問、醫療服務提供者和政府相關人員的訪談，並輔以公司文件、資料庫、投資報告以及醫學和商業文獻等二手資料。收入按服務提供者和支付方類型累計，並考慮了合約調整和收費系統。

針對關鍵相關人員和決策者的市場調查

《全球臨床實驗室服務市場（第 11 版）》專為診斷和檢測公司的管理人員和策略團隊、對終端市場需求進行基準測試的體外診斷 (IVD) 製造商、評估市場佔有率和未開發市場機會的競爭對手、評估整合前景的投資者和企業發展團隊，以及尋求對細分市場和區域成長有深刻見解的行銷和銷售領導者而設計。

Now in its 11th edition, Kalorama Information’s flagship review of clinical laboratory services gives decision-makers a rigorous, independent read on where diagnostic testing revenue sits today and where it is heading. Built on a 2025 base year, with historical data spanning 2020–2024 and forecasts running through 2030, the report is the reference stakeholders use to size markets, benchmark competitors, and pressure-test strategy against demographic, clinical, technological, and reimbursement realities.

Why this report matters now

Clinical laboratories sit at the center of the diagnostic process and are among the largest end-users of in vitro diagnostics, informing decisions across chemistry, hematology, immunology, microbiology, anatomic pathology, genetics, and molecular diagnostics. The care setting for those tests is shifting quickly — outward to outpatient, ambulatory, retail, and home-based collection, and simultaneously inward, as high-complexity molecular and genomic work concentrates in reference labs, academic centers, and specialty facilities. Layer on aging populations, rising chronic disease burden, oncology’s growing dependence on molecular and companion diagnostics, persistent pricing and reimbursement pressure, staffing shortages, and accelerating consolidation, and the competitive terrain is being redrawn. This edition maps that terrain with data, not conjecture.

What’s inside

Market sizing and forecasts: Global revenues at the service-provider level, with year-by-year historical performance, 2025–2030 projections, and CAGRs supplied for every major segment.

Testing services by specialty: Discrete sizing, trend lines, and growth forecasts for six segments: essential and routine testing (clinical chemistry, hematology, coagulation, endocrinology), immunology and microbiology, cytology and histology, genetic testing, toxicology (drugs of abuse), and COVID-19 — including where post-pandemic normalization is redistributing volume toward traditional and specialized testing.

Market by provider group: Analysis breakdowns across hospital and acute-care labs, physician and outpatient providers, and independent and reference laboratories, contextualized with hospital-bed and physician-density benchmarks and settings such as nursing, home health, dialysis, and pharmacy-based labs.

Regional depth across four regions and 15 countries: North America (United States, Canada); EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland); Asia Pacific (Japan, China, India, South Korea, Australia); and Latin America (Brazil, Mexico) — each with country-level market values, performance histories, and growth projections, plus industry-structure detail for key markets.

Regulatory and reimbursement intelligence: Practical coverage of the forces that move margins: CLIA structure and certification trends, laboratory-developed test regulation, EU IVDR, Medicare reimbursement trajectories, PAMA and the CARES Act, SALSA, ADLT designations, ESRD consolidated billing, commercial-payer dynamics, and pricing transparency.

Competitive analysis and company profiles: A market-share analysis of leading providers plus profiles of the companies shaping global competition — among them ARUP, BioReference Health, DaVita, Eurofins Scientific, Exact Sciences, Guardant Health, H.U. Group, Labcorp, Medicover, Myriad Genetics, Natera, Quest Diagnostics, Siemens Healthineers, Sonic Healthcare, SYNLAB, and Unilabs — with corporate detail, revenue histories, and acquisition, alliance, and partnership activity.

The trends that will define 2025–2030: A dedicated analysis of AI, machine learning, and lab automation; molecular and advanced testing; digital pathology; multiplex testing; personalized medicine; consolidation and centralized networks; pricing and reimbursement pressure; and staffing shortages.

Methodology you can stand behind

Findings draw on primary interviews with industry officials, consultants, providers, and government sources, complemented by secondary research across company filings, databases, investment reports, and medical and business literature. Revenues are recognized at the service-provider level across payer types, with contractual adjustments and fee arrangements accounted for.

Market research for key stakeholders and decision-makers

Worldwide Market for Clinical Laboratory Services, 11th Edition is designed for C-suite executives and strategy teams at diagnostics and laboratory companies, IVD manufacturers benchmarking end-market demand, competitors evaluating market share and white-space opportunities, investors and corporate development teams assessing consolidation prospects, and marketing and commercial leaders seeking a defensible view of segment and regional growth.

CHAPTER ONE: EXECUTIVE SUMMARY

INDUSTRY AT A GLANCE

SCOPE AND METHODOLOGY

GLOBAL MARKET OVERVIEW

Figure 1-1: Factors Impacting Clinical Lab Demands, 2025
Table 1-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)
Figure 1-2: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)

KEY ISSUES AND TRENDS AFFECTING THE MARKET

LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

CLINICAL LABORATORY DESCRIPTION

Figure 2-1: Clinical Laboratory Order
Figure 2-2: Hospital Length of Stay in Days, by Country, 2021 (Average)

Laboratory Service Payer Types

Table 2-1: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2025 (%)
Figure 2-3: Clinical Laboratory Revenues, by Client and Payer Type, 2025 Estimates (%)

THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES

Structure and Regulation in the U.S.

Certificate of Waiver
Table 2-2: Selected CLIA Waived Laboratory Tests
Certificate of Provider-Performed Microscopy Procedures (PPMP)
Table 2-3: Provider-Performed Microscopy Procedures
Certificate of Compliance and Certificate of Accreditation
Figure 2-4: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), April 2025 (%)
Table 2-4: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), as of April 2024
Figure 2-5: Laboratory Certificate Trends, by Application Type, July 2010 – April 2024
States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
Table 2-5: CLIA-Exempt States, Number of Laboratories, as of April 2024

CLINICAL LABORATORY IMPROVEMENT AND QUALITY

LABORATORY DEVELOPED TEST REGULATIONS

Directive 2017/746 (IVDR)

PAYERS AND REIMBURSEMENT

Figure 2-6: Positive Forces and Negative Forces Impacting Clinical Laboratory Services, 2026

Trends in Medicare Reimbursement

Figure 2-7: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2025

Protecting Access to Medicare Act (PAMA) of 2014

Impact of CARES Act on PAMA

Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2027 (%)
Saving Access to Laboratory Service Act (SALSA)

Advanced Laboratory Tests (ADLT)

Table 2-7: List of Approved ADLTs, 2025

Bundled Insurance Payments for ESRD Patients

Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing, CY 2025

Commercial Insurance Providers

Table 2-9: National Commercial Insurance Provider List Revenues, 2025 (US$ billion)
Figure 2-8: National Commercial Insurance Providers by Membership and Total Revenues, 2025 (US$ billion)

TRANSPARENCY IN PRICING

THE ROLE OF INFORMATION TECHNOLOGY

Table 2-10: Selected Laboratory Information Management System Providers, 2025 Vendor List

INDUSTRY DRIVERS

Global Demographics

Table 2-11: The Global Population, 1980-2060 (millions)
Figure 2-9: The Global Population, 1980-2060 (in millions of population)
Regional Population Overview
Table 2-12: World Population by UN-Defined Geographic Region, 2010–2060 (millions)
Figure 2-10: World Population by UN-Defined Geographic Region, 2010–2060 (in millions of population)
Aging Populations
Table 2-13: Global Population Trends Age 65+, 2000-2060 (population in millions)
Figure 2-11: Global Population Trends Age 65+, 2000-2060 (population in millions)

Chronic Diseases and Conditions

Figure 2-12: Global Prevalence of Disease, 2000, 2015 and Projected 2030 (in millions of population)
Figure 2-13: Leading Causes of Death Globally, 2021 (number of deaths in millions)

Economic Performance

Health Expenditures
Figure 2-14: Global Health Spending as a Percentage of GDP, by Country, 2023 estimates (%)

Laboratory Performance Drivers and Challenges

Drivers
Challenges

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

TEST AND SERVICES OVERVIEW

Figure 3-1: Global Clinical Laboratory Market Analysis, Service Revenue Trend, 2020-2030 (US$ millions)
Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment, 2020-2030 (US$ millions at the manufacturer’s level) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]
Figure 3-2: Global Clinical Laboratory Market Analysis, by Segment Growth Forecast, 2025-2030 (%) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]
Figure 3-3: Global Clinical Laboratory Market Analysis by Testing Service, Distribution of Revenues, 2025 (%) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]

CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING

Figure 3-4: Global Clinical Laboratory Market Analysis, Clinical Chemistry: Routine & Essential Testing Service Market Trend, 2020-2030 ($ millions)
Table 3-2: Market Overview - Routine and Essential Testing, 2025 (US$ millions)

Routine Clinical Chemistry

Cholesterol Level Testing

Table 3-3: High Cholesterol Risk Categories

Urinalysis

Table 3-4: Normal Reference Levels in a Medical Urinalysis

Hematology

Blood Cell Count
Table 3-5: Laboratory Reference Parameters for CBC

Coagulation

Endocrinology

Thyroid Function Tests
Pregnancy Testing
Table 3-6: hCG Levels in Pregnant Women by Days Past Ovulation

IMMUNOLOGY AND MICROBIOLOGY

Figure 3-5: Global Clinical Laboratory Market Analysis, Immunology & Microbiology Testing Service Market Trend, 2020-2030 ($ millions)
Table 3-7: Market Overview - Immunology & Microbiology Testing, 2025 (US$ millions)

Allergy and Food Intolerance

Tumor Markers

Cardiac Markers

HIV Testing

CYTOLOGY AND HISTOLOGY TESTING

Figure 3-6: Global Clinical Laboratory Market Analysis, Cytology & Histology Testing Service Market Trend, 2020-2030 ($ millions)
Table 3-8: Market Overview - Cytology & Histology Testing, 2025 (US$ millions)
Pap Test
Figure 3-7: Percent of Females Aged 30-49 Screened for Cervical Cancer (all screening methods), by Select Country, 2019 Estimates (%)
Figure 3-8: Summary Recommendations: WHO Suggests Using the Following Strategy for Cervical Cancer Prevention

GENETIC TESTING

Figure 3-9: Global Clinical Laboratory Market Analysis, Genetic Testing Service Market Trend, 2020-2030 ($ millions)
Table 3-9: Market Overview - Genetic Testing, 2025 (US$ millions)

TOXICOLOGY TESTING

Figure 3-10: Global Clinical Laboratory Market Analysis, Toxicology Testing Service Market Trend, 2020-2030 ($ millions)
Table 3-10: Substance Detection Periods, by Selected Test Method

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW

Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment, 2025 and 2030 (US$ millions)
Figure 4-1: Global Clinical Laboratory Market Analysis, CAGR Forecast by Provider Segment, 2025–2030 (%)
Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues, 2025 (%)

HOSPITALS AND ACUTE CARE PROVIDERS

Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)
Figure 4-3: Hospital Beds per 1,000 Population, by Country, 2023/2024
Figure 4-4: Global Visualization - Hospital Beds per 1,000 Population, by Country, 2023/2024

PHYSICIANS AND OUTPATIENT CARE PROVIDERS

Figure 4-5: Physician-based Laboratory Testing Markets, 2023-2025 (US$ millions)
Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)

Physician Offices

Figure 4-6: Medical Doctors per 1,000 Population by Country, 2023/2024
Figure 4-7: Global Visualization - Medical Doctors per 1,000 Population by Country, 2023/2024

Global Nursing Establishments and Assisted Living Facilities

Global Dialysis Clinics

INDEPENDENT LABORATORY PROVIDERS

Figure 4-8: Independent Laboratory Testing Markets, 2023-2025 (US$ millions)
Table 4-4: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)

CHAPTER FIVE: NORTH AMERICA MARKET

OVERVIEW

Table 5-1: North America Market Value by Country, 2025 (US$ millions at the manufacturer’s level)

UNITED STATES

Table 5-2: United States Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 5-1: United States Clinical Laboratory Service Market, Performance, 2010-2025 (US$ millions)

U.S. Market by Test Type

Table 5-3: United States Clinical Laboratory Service Market, by Testing Services, Estimates and Forecast 2025 and 2030 (US$ millions) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]
Figure 5-2: U.S. Clinical Laboratory Market Analysis, Testing Service Revenues by Type, 2025 (%) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]
Figure 5-3: U.S. Clinical Laboratory Market Analysis, Testing Service Revenues Over Time by Type, 2020-2030 (US$ millions) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]

U.S. Market by Laboratory Provider Type

Table 5-4: United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 5-4: United States Clinical Laboratory Market Share, by Laboratory Type, 2025 (%)
Figure 5-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time by Laboratory Type, 2020-2030 (US$ millions)

U.S. Clinical Laboratory Industry Structure

Figure 5-6: Growth in Clinical Laboratories, 2000-2024
CLIA Laboratory Registration, Laboratories by Type
Figure 5-7: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory/Facility Type, May 2024 (number of labs)
Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), May 2024
Figure 5-8: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), June 2020 and May 2024
Figure 5-9: Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, Percent Change, Compounded Annually 2020-2024 (%)

Independent Clinical Laboratories

Figure 5-10: Leading U.S. Independent Laboratory Groups, Distribution of Centers, 2025 (%)
Growth in Independent Clinical Laboratories
Figure 5-11: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024 (number of laboratories)

Hospital-based Laboratories

U.S. Hospital Data
Table 5-6: U.S. Hospital Types
Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2011 through 2024
Table 5-8: AHA Statistics for U.S. Hospitals, 2015-2024
U.S. Hospital Stay Stats
Figure 5-12: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021 (days of hospital stay)
Growth in Hospital Clinical Laboratories
Figure 5-13: Growth in U.S. Hospital Laboratory Locations, June 2011 through April 2024 (number of laboratories)
Number of U.S. Physicians
Growth in Clinical Laboratories in the Physician's Office
Figure 5-14: Growth in U.S. Physician Office Laboratory Locations, June 2011 through April 2024 (number of laboratories)

Nursing Facility and Home Health

U.S. Nursing Home Establishments
U.S. Home Health Facilities
Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
Figure 5-15: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011 through April 2024 (number of laboratories)

Pharmacy-based Laboratories

Growth in Pharmacy-Based Clinical Laboratories
Figure 5-16: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through April 2024 (number of laboratories)

Dialysis Clinics

Growth in U.S. Dialysis Clinics and Affiliated Laboratories
Figure 5-17: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through April 2024 (number of laboratories)

CANADA

Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 5-18: Canada Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER SIX: EMEA MARKET

OVERVIEW

Table 6-1: EMEA Market Value, by Country, 2025 (US$ millions at the manufacturer’s level)
Figure 6-1: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

GERMANY

Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-2: Germany Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)
Figure 6-3: Germany’s Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, 2025 (%)

FRANCE

Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-4: France Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

ITALY

Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-5: Italy Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SPAIN

Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-6: Spain Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

UNITED KINGDOM

Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-7: United Kingdom Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SWITZERLAND

Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 6-8: Switzerland Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER SEVEN: ASIA PACIFIC MARKET

OVERVIEW

Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2025
(US$ millions at the manufacturer’s level)
Figure 7-1: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

JAPAN

Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 7-2: Japan Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions) Japan Clinical Laboratory Industry Structure
Figure 7-3: Japan Clinical Laboratory Industry, by Type, 2025 (%)
Figure 7-4: Japan Clinical Laboratory Industry, by Test Classification, 2023-2024 (%)
Figure 7-5: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2025 (%)

CHINA

Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 7-6: China Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions) China Clinical Laboratory Industry Structure
Figure 7-7: China Clinical Laboratory Industry, by Type, 2025 (%)

INDIA

Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 7-8: India Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SOUTH KOREA

Table 7-5: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 7-9: South Korea Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

AUSTRALIA

Table 7-6: Australia Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 7-10: Australia Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER EIGHT: LATIN AMERICA MARKET

OVERVIEW

Table 8-1: Latin America Market Value, by Country, 2025 (US$ millions at the manufacturer’s level)
Figure 8-1: Latin America Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

BRAZIL

Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 8-2: Brazil Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

MEXICO

Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
Figure 8-3: Mexico Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER NINE: LEADING MARKET PARTICIPANTS

GLOBAL COMPETITOR SUMMARY

Figure 9-1: Market Participants, Global Service Revenues, Estimated 2024 and 2025 (US$ millions) U.S. COMPETITIVE ANALYSIS
Table 9-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2025 (US$ millions)
Figure 9-2: Estimated U.S. Laboratory Service Market Share Among Leading Clinical Laboratory Providers, 2025 (%)
Figure 9-3: Top 15 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2025 (US$ millions)

SELECT COMPANY PROFILES

ARUP LABORATORIES

Company Overview

Table 9-2: ARUP Laboratories Details
Figure 9-4: ARUP Labs Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY

Company Overview

Table 9-3: BioReference Health Corporate Details
Figure 9-5: BioReference Labs Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

DAVITA

Company Overview

Table 9-4: DaVita Corporate Details
Figure 9-6: DaVita Labs Revenues, 2015-2025 (US$ millions)

Products and Services

EUROFINS SCIENTIFIC SE

Company Overview

Table 9-5: Eurofins Scientific Corporate Details
Figure 9-7: Eurofins Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

EXACT SCIENCES CORP.

Company Overview

Table 9-6: Exact Sciences Corporate Details
Figure 9-8: Exact Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

GUARDANT HEALTH

Company Overview

Table 9-7: Guardant Health Corporate Details
Figure 9-9: Guardant Health Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

H.U. GROUP HOLDINGS

Company Overview

Table 9-8: H.U. Group Holdings, Inc. Corporate Details
Figure 9-10: H.U Group Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

LABORATORY CORPORATION OF AMERICA (LABCORP)

Company Overview

Table 9-9: Laboratory Corporation of America Corporate Details
Figure 9-11: Labcorp Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

MEDICOVER AB

Company Overview

Table 9-10: Medicover Corporate Details
Figure 9-12: Medicover Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

MYRIAD GENETICS, INC.

Company Overview

Table 9-11: Myriad Genetics Corporate Details
Figure 9-13: Myriad Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

NATERA

Company Overview

Table 9-12: Natera Corporate Details
Figure 9-14: Natera Revenues, 2019-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

QUEST DIAGNOSTICS, INC.

Company Overview

Table 9-13: Quest Diagnostics Corporate Details
Figure 9-15: Quest Diagnostics Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SIEMENS HEALTHINEERS

Company Overview

Table 9-14: Siemens Healthineers Corporate Details
Figure 9-16: Siemens Healthineers Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SONIC HEALTHCARE LIMITED

Company Overview

Table 9-15: Sonic Healthcare Corporate Details
Figure 9-17: Sonic Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SYNLAB INTERNATIONAL GMBH

Company Overview

Table 9-16: SYNLAB Corporate Details
Figure 9-18: SYNLAB Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

UNILABS

Company Overview

Table 9-17: Unilabs Corporate Details
Figure 9-19: Unilabs Revenues, 2015-2025 (US$ millions)

Products and Services

CHAPTER TEN: MARKET TRENDS AND SUMMARY

GLOBAL MARKET OVERVIEW

Table 10-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)
Figure 10-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)

REGIONAL OVERVIEW

Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2025 (US$ millions at the manufacturer’s level)
Figure 10-2: Global Clinical Laboratory Market Analysis, Revenues by Region, 2025 (%)
Figure 10-3: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2025-2030 (%)

CLINICAL LABORATORY SERVICES ISSUES AND TRENDS

Population growth

Aging populations

Increasing disease burden

Consolidation and Centralized Laboratory Networks

Pricing Pressures in Clinical Laboratory Services

Reimbursement Pressures

Focusing on Efficient health systems

Overall growth in demand for health care services

Laboratory-Developed Tests

Regulatory Developments in Clinical Laboratory Services

Multiplex Testing